🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Some professionals said the demand for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has removed violative material and banned associated keywords and query recommendations. The company stated it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also found groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, positive reviews and detailed instructions for preparing or administering at home.

Within moments of joining one group, a seller posted contact information, where most transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these groups, messages show dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service said it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Although the research behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially serious health risks”.